These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5000465)

  • 21. Nonsurgical management options in impotence.
    Morales A
    Hosp Pract (Off Ed); 1993 Mar; 28(3A):15-6, 19-20, 23-4. PubMed ID: 8450002
    [No Abstract]   [Full Text] [Related]  

  • 22. Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled double-blind crossover study.
    Kunelius P; Häkkinen J; Lukkarinen O
    Urology; 1997 Mar; 49(3):441-4. PubMed ID: 9123711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experience in the use of sustanon-250, a hormonal drug with delayed action, in sexological practice].
    Neshkov NS; Kukurekin IuV
    Vrach Delo; 1972 Aug; 8():124-7. PubMed ID: 5073159
    [No Abstract]   [Full Text] [Related]  

  • 25. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
    Cavallini G; Caracciolo S; Vitali G; Modenini F; Biagiotti G
    Urology; 2004 Apr; 63(4):641-6. PubMed ID: 15072869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Administration of testosterone as an addition to the treatment of impotence of organic origin].
    Jevtich MJ
    J Urol (Paris); 1985; 91(5):305. PubMed ID: 4078355
    [No Abstract]   [Full Text] [Related]  

  • 27. Double-blind trial of yohimbine in treatment of psychogenic impotence.
    Reid K; Surridge DH; Morales A; Condra M; Harris C; Owen J; Fenemore J
    Lancet; 1987 Aug; 2(8556):421-3. PubMed ID: 2887726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yohimbine in the treatment of male erectile dysfunction.
    Ashton AK
    Am J Psychiatry; 1994 Sep; 151(9):1397. PubMed ID: 8067505
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacotherapy of erectile dysfunction].
    Kovalev VA; Koroleva SV; Kamalov AA
    Urologiia; 2000; (1):33-8. PubMed ID: 16856460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen deficiency in the etiology and treatment of erectile dysfunction.
    Gore JL; Swerdloff RS; Rajfer J
    Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yohimbine and psychogenic impotence.
    Lancet; 1987 Nov; 2(8567):1088. PubMed ID: 2889995
    [No Abstract]   [Full Text] [Related]  

  • 32. Nonhormonal pharmacological treatment of organic impotence.
    Morales A; Surridge DH; Marshall PG; Fenemore J
    J Urol; 1982 Jul; 128(1):45-7. PubMed ID: 6125605
    [No Abstract]   [Full Text] [Related]  

  • 33. Yohimbine for male sexual dysfunction.
    Med Lett Drugs Ther; 1994 Dec; 36(938):115-6. PubMed ID: 7990753
    [No Abstract]   [Full Text] [Related]  

  • 34. Erectile dysfunction in aging men: testosterone role in therapeutic protocols.
    Caretta N; Ferlin A; Palego PF; Foresta C
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):108-11. PubMed ID: 16760637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of topically applied vasoactive agents and testosterone versus testosterone in the treatment of erectile dysfunction in aged men with low sexual interest.
    Gomaa A; Eissa M; El-Gebaley A
    Int J Impot Res; 2001 Apr; 13(2):93-9. PubMed ID: 11426345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic choices of penile erectile dysfunction].
    Bai WJ; Wang XF; Jiang XT; Qu HW; Zhu JC
    Zhonghua Nan Ke Xue; 2002; 8(5):332-4. PubMed ID: 12479119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and hormonal effects of testosterone undecanoate (TU) in male sexual impotence.
    Klepsch I; Măicănescu-Georgescu M; Marinescu L
    Endocrinologie; 1982; 20(4):289-93. PubMed ID: 6818673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient satisfaction with testosterone supplementation for the treatment of erectile dysfunction.
    Monga M; Kostelec M; Kamarei M
    Arch Androl; 2002; 48(6):433-42. PubMed ID: 12425760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An evidence-based approach to writing reviews as illustrated by treatment of erectile dysfunction].
    Apolikhin OP; Abdullin II
    Urologiia; 2005; (5):31-5. PubMed ID: 16281837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer after exogenous testosterone treatment for impotence.
    Loughlin KR; Richie JP
    J Urol; 1997 May; 157(5):1845. PubMed ID: 9112543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.